Cullen Kills Rev. Florian Gall with Digoxin

Charles Cullen’s killing of Reverend Florian Gall at Somerset Medical Center turned a patient’s unexpected death into a confirmed homicide and a difficult criminal investigation. Gall had been critically ill, then improved enough for his do-not-resuscitate order to be rescinded and his digoxin discontinued. When he suffered cardiac arrest on June 28, his blood contained an extraordinary amount of the drug. Toxicology later confirmed digoxin poisoning; the hospital called him Patient 4, acknowledging that his death was not the first suspicious case under review.

Illness, Treatment, and Recovery

Gall arrived at the Somerset Medical Center intensive care unit with a severe infection, probably pneumonia. His fever reached three digits, his lymph nodes were markedly swollen, and his lungs struggled to supply oxygen to his heart and brain. A ventilator supported his breathing while a machine filtered his blood as his kidneys began to fail. For a time, his prospects were uncertain. His family agreed to a do-not-resuscitate order, which would have limited extraordinary measures if his body failed.

Gall’s heart presented a separate problem: atrial fibrillation, in which a chamber contracted too rapidly to fill and pump effectively. A cardiologist prescribed digoxin to slow the rhythm and help oxygenated blood circulate. The drug was thus part of legitimate treatment at first, not an unexplained substance in a patient who had never received it. As Gall’s pneumonia subsided and his heart rhythm stabilized, his condition improved. His DNR order was rescinded, digoxin was discontinued, and by the second week he could sit up, eat, and talk with his sister. He remained irritable about the tubes and machines, but he was recognizably himself and might have left the hospital if the recovery continued.

Access and the Fatal Reversal

Gall’s sister, Lucille, visited daily. A senior nurse at a nearby hospital, she was allowed to remain at his bedside late and questioned aspects of his care, including the drugs he received. Cullen, who was not always assigned to Gall, checked on him regularly. Her challenges irritated him; the narrative notes that when Cullen thought of Gall, he pictured the sister instead. It also places his opportunity after her departure, when he could attend to what he had been planning. The account links that access and hostility to the killing without identifying a specific injection scene or establishing the precise moment the fatal dose was given.

Cullen’s work offered repeated access to patients and medicines in a setting where ordinary nursing actions could be difficult to distinguish from harmful ones. Elsewhere, he used an IV piggyback port to administer clear digoxin under the appearance of flushing a line, and he also manipulated medication in the supply room. Those episodes show how his conduct could be concealed within routine care, but they do not establish the exact method used against Gall. In Gall’s case, the decisive evidence is the patient’s sudden collapse after improvement and the toxicology that followed.

At approximately 9:32 a.m. on June 28, Gall unexpectedly went into cardiac arrest. Staff attempted resuscitation, but the measures failed; his recorded time of death was 10:10 a.m. His bloodwork showed digoxin levels far beyond the expected range. The death was therefore not simply the final stage of the pneumonia and organ failure that had brought him to the unit: the drug evidence contradicted the appearance of a natural decline.

Toxicology and the Homicide Finding

The Somerset Medical Center administration initially handled the case internally and quickly. Pharmacy was asked to examine Pyxis records around the dates of the digoxin deaths, while assistant pharmacist Nancy Doherty contacted the New Jersey Poison Control Center to determine how much digoxin could produce the levels found in Gall. The question put to the center was principally one of calculation. The hospital’s label for him—Patient 4—placed his death within a suspected series rather than treating it as an isolated clinical anomaly.

Gall’s toxicology report arrived on November 29, 2003. The tests screened for roughly ninety-six drugs, from acetaminophen to zolpidem. They found digoxin in several tissues: 23.4 mcg/l in the vitreous fluid, 32.0 mcg/kg in the spleen, 40.8 mcg/kg in the heart, and 104 mcg/kg in the kidney. With those results, Nobby C. Mambo amended the report to list the cause of death as digoxin toxicity and the manner of death as homicide. The report established both a murder victim and the weapon, converting suspicion into a forensic conclusion.

Investigative Significance and Limits

The toxicology finding did not, by itself, prove who administered the drug. Investigators had Pyxis reports and Cerner printouts that connected Cullen to opportunities to obtain medication, but access was not the same as proof of murder. Cullen could offer explanations for medication orders and cancellations, while the records could not establish that he had administered the fatal dose. The evidence had moved the case from a suspicious death to homicide, yet the central attribution problem remained.

That gap gives Gall’s death its investigative significance. His improving condition, the discontinuation of digoxin, the abrupt arrest, and the extreme tissue levels form a clear sequence of medical contradiction: recovery gave way to a death that the chemistry could explain but the hospital record alone could not fully reconstruct. Gall’s case supplied investigators with a confirmed killing and a specific poison, while leaving them to seek evidence that would connect Cullen to the act beyond reasonable doubt.